| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Oct 1, 2025 | Oct 3, 2025 | Longeveron Inc. | Chief Medical Officer | Sell | 27.5 | -11,883 | -4.98% | ✗ | $8.8K |
| Jul 1, 2025 | Jul 3, 2025 | Longeveron Inc. | Chief Medical Officer | Sell | 27.5 | -7,431 | -5.16% | ✗ | $9.5K |
| Apr 1, 2025 | Apr 3, 2025 | Longeveron Inc. | Chief Medical Officer | Sell | 26.3 | -7,566 | -4.99% | ✗ | $11.3K |
| Jan 2, 2025 | Jan 6, 2025 | Longeveron Inc. | Chief Medical Officer | Sell | 26.3 | -6,120 | -3.88% | ✗ | $11K |
| Oct 1, 2024 | Oct 3, 2024 | Longeveron Inc. | Chief Medical Officer | Sell | 27.5 | -5,316 | -3.26% | ✗ | $10K |
| Aug 15, 2024 | Aug 19, 2024 | Longeveron Inc. | Chief Medical Officer | Sell | 91.3 | +161,359 | 9111.18% | ✗ | $35.4K |
| May 2, 2024 | May 6, 2024 | Longeveron Inc. | Chief Medical Officer | Sell | 27.5 | -308 | -14.81% | ✗ | $871.6 |
| Jan 2, 2024 | Jan 25, 2024 | Longeveron Inc. | Chief Medical Officer | Sell | 27.5 | -3,074 | -12.88% | ✗ | $4.1K |
| Oct 2, 2023 | Oct 4, 2023 | Longeveron Inc. | Chief Medical Officer | Sell | 27.5 | -3,059 | -11.36% | ✗ | $7K |
| Aug 18, 2023 | Aug 22, 2023 | Longeveron Inc. | Chief Medical Officer | Sell | 26.3 | -3,081 | -10.27% | ✗ | $10.4K |